where specialists connect on complex cases

Psoriasis, Psoriatic Arthritis,
Rheumatoid Arthritis,
Spondyloarthropathies,
Crohn’s Disease and
Ulcerative Colitis

REGISTER NOW

Optimizing Interdisciplinary Care for the Management of Immune-Mediated Inflammatory Diseases

IAS 2018 is the only event of its kind that brings together rheumatologists, dermatologists, gastroenterologists, immunologists, internists, and other HCPs to debate, discuss and collaborate on optimal treatment strategies for immune-mediated inflammatory diseases (IMIDs).

Attend IAS. Register Today.

Highlights

For three days, share strategies with the very best minds in the field, embrace innovation, and learn about the vital role emerging therapies play in the treatment of patients with immune-mediated inflammatory diseases (IMIDs) such as:

PSORIASIS

PSORIATIC ARTHRITIS

RHEUMATOID ARTHRITIS

SPONDY-LOARTHRITIS

CROHN'S DISEASE AND Ulcerative Colitis

Senior Advisors

Leonard H. Calabrese

DO

Professor of Medicine
Cleveland Clinic Lerner
College of Medicine
Case Western Reserve University
Cleveland, Ohio

Joel M. Gelfand

MD, MSCE

Associate Professor of Dermatology and Epidemiology Perelman School of Medicine
Univeristy of Pennsylvania
Philadelphia, Pennsylvania

Stephen B. Hanauer

MD

Clifford Joseph Barborka
Professor of Medicine
Northwestern University
Chicago, Illinois

Co-Chairs

Adam S. Cheifetz

MD

Director, Center for Inflammatory Bowel Disease
Beth Israel Deaconess Medical Center
Associate Professor of Medicine
Harvard Medical School

Joseph F. Merola

MD, MMSc

Assistant Professor
Harvard Medical School

Mital Patel

MD

Director, Hidradenitis Suppurativa and Neutrophilic Dermatoses Clinic
Assistant Program Director, Dermatology and Rheumatology Fellowship
Instructor in Dermatology, Harvard Medical School
Associate Physician, Brigham and Women’s Hospital, Department of Dermatology

We each care for patients, teach, and conduct research in a specific, discipline-focused universe. When we come together to listen to, converse with, and understand the perspectives of experts from other medical disciplines within the autoimmune disease field, the boundaries of our knowledge are expanded, which in turn enriches our research, teaching, and care of patients.

Philip J. Mease, MD

Clinical Professor of Medicine, University of Washington School of Medicine, Director of Rheumatology Clinical Research, Swedish Medical Center, Seattle Rheumatology Associates

There’s a growing realization that inflammatory diseases are not linked to any one organ system. So many specialties are involved, and each has insights. I first joined IAS because I am excited to learn from colleagues in other specialties. I keep coming back because of the new insights I gain each time I attend the IAS meeting.

Steven R. Feldman, MD, PhD

Wake Forest University School of Medicine, Professor of Dermatology, Pathology, and Public Health Sciences

IAS speakers were excellent and the quality of the presentations were outstanding. I will definitely attend every year!

Paul S. Yamauchi, MD, PhD

Clinical Assistant Professor of Dermatology, David Geffen School of Medicine at UCLA, Adjunct Associate Professor John Wayne Cancer Institute, Dermatology Institute & Skin Care Center, Inc., Clinical Science Institute

previous next

Recent News

Introducing IAS360.com

Friday, August 11, 2017 - 12:33

Introducing the launch of IAS360.com.

The network was created to fill an unmet need in the auto-immune space, providing specialists with a year-...

Read more

IAS Receives Endorsement from the AGA Institute

Tuesday, March 7, 2017 - 14:34

MALVERN, PA (Tuesday, March 7, 2017) — The IAS, the nation’s leading autoimmune conference and exhibition, today announced that it has received endorsement from the AGA...

Read more

Keep Me Informed

Sign up for news alerts

5 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Contact Us

18 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.